Engineered Fe3O4-based nanomaterials for diagnosis and therapy of cancer
Malignant tumor is one of the major public health problems seriously threatening the health of people all over the world. Great effort is being devoted to the development of theranostic nanoplatforms to satisfy the demand for precise diagnosis and efficient therapy. Recently, the Fe3O4 nanoparticles...
Gespeichert in:
| Veröffentlicht in: | New journal of chemistry 2021-05, Vol.45 (18), p.7918-7941 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7941 |
|---|---|
| container_issue | 18 |
| container_start_page | 7918 |
| container_title | New journal of chemistry |
| container_volume | 45 |
| creator | Zhang, Yiwei Li, Xinxin Zhang, Yajie Wei, Jun Wang, Wei Dong, Changzhi Xue, Yanan Liu, Min Pei, Renjun |
| description | Malignant tumor is one of the major public health problems seriously threatening the health of people all over the world. Great effort is being devoted to the development of theranostic nanoplatforms to satisfy the demand for precise diagnosis and efficient therapy. Recently, the Fe3O4 nanoparticles (NPs) approved by the Food and Drug Administration (FDA) have been extensively explored in cancer diagnosis and the administration of therapeutic drugs thanks to their unique properties such as T1/T2-weighted magnetic resonance (MR) imaging, magnetic targeting, magnetic hyperthermia, and photodynamic/photothermal therapy. Thus, Fe3O4 NPs together with other organic or inorganic materials are developed as theranostic nanoplatforms, thereby having the chance to compete with Gd-based contrast agents in clinics. Therefore, Fe3O4-based theranostic nanoplatforms have the potential to be used in individual therapies in the near future. In this review, the recent progress in fabricating Fe3O4-based theranostic nanoplatforms is summarized and their applications in biomedical area are also highlighted. |
| doi_str_mv | 10.1039/d1nj00419k |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2524684622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2524684622</sourcerecordid><originalsourceid>FETCH-LOGICAL-p183t-d30e665a0626fcbddb9913f223b94e49151a5ec34ee3593f1b1240f9d56fb5933</originalsourceid><addsrcrecordid>eNotjcFKAzEURYMoWKsbvyDgejQveYnNUkprhUI3ui7J5KVO1WRMpgv_3oCu7uFyuJexWxD3IJR9CJCOQiDYjzM2A2VsZ6WB88aA2AmN5pJd1docgEcDM7ZZpcOQiAoFvia1w8672ji5lL_cRGVwn5XHXHgY3CHlOlTuUuDTOxU3_vAcee9ST-WaXcSm0s1_ztnbevW63HTb3fPL8mnbjbBQUxeUIGO0E0aa2PsQvLWgopTKWyS0oMFp6hUSKW1VBA8SRbRBm-hboebs7m93LPn7RHXaH_OppHa5l1qiWaBpY7-ttkzf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524684622</pqid></control><display><type>article</type><title>Engineered Fe3O4-based nanomaterials for diagnosis and therapy of cancer</title><source>Royal Society Of Chemistry Journals</source><source>Alma/SFX Local Collection</source><creator>Zhang, Yiwei ; Li, Xinxin ; Zhang, Yajie ; Wei, Jun ; Wang, Wei ; Dong, Changzhi ; Xue, Yanan ; Liu, Min ; Pei, Renjun</creator><creatorcontrib>Zhang, Yiwei ; Li, Xinxin ; Zhang, Yajie ; Wei, Jun ; Wang, Wei ; Dong, Changzhi ; Xue, Yanan ; Liu, Min ; Pei, Renjun</creatorcontrib><description>Malignant tumor is one of the major public health problems seriously threatening the health of people all over the world. Great effort is being devoted to the development of theranostic nanoplatforms to satisfy the demand for precise diagnosis and efficient therapy. Recently, the Fe3O4 nanoparticles (NPs) approved by the Food and Drug Administration (FDA) have been extensively explored in cancer diagnosis and the administration of therapeutic drugs thanks to their unique properties such as T1/T2-weighted magnetic resonance (MR) imaging, magnetic targeting, magnetic hyperthermia, and photodynamic/photothermal therapy. Thus, Fe3O4 NPs together with other organic or inorganic materials are developed as theranostic nanoplatforms, thereby having the chance to compete with Gd-based contrast agents in clinics. Therefore, Fe3O4-based theranostic nanoplatforms have the potential to be used in individual therapies in the near future. In this review, the recent progress in fabricating Fe3O4-based theranostic nanoplatforms is summarized and their applications in biomedical area are also highlighted.</description><identifier>ISSN: 1144-0546</identifier><identifier>EISSN: 1369-9261</identifier><identifier>DOI: 10.1039/d1nj00419k</identifier><language>eng</language><publisher>Cambridge: Royal Society of Chemistry</publisher><subject>Biomedical materials ; Cancer ; Contrast agents ; Diagnosis ; Gadolinium ; Hyperthermia ; Inorganic materials ; Iron oxides ; Magnetic properties ; Magnetic resonance imaging ; Nanomaterials ; Nanoparticles ; Public health ; Regulatory agencies ; Therapy</subject><ispartof>New journal of chemistry, 2021-05, Vol.45 (18), p.7918-7941</ispartof><rights>Copyright Royal Society of Chemistry 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Zhang, Yiwei</creatorcontrib><creatorcontrib>Li, Xinxin</creatorcontrib><creatorcontrib>Zhang, Yajie</creatorcontrib><creatorcontrib>Wei, Jun</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Dong, Changzhi</creatorcontrib><creatorcontrib>Xue, Yanan</creatorcontrib><creatorcontrib>Liu, Min</creatorcontrib><creatorcontrib>Pei, Renjun</creatorcontrib><title>Engineered Fe3O4-based nanomaterials for diagnosis and therapy of cancer</title><title>New journal of chemistry</title><description>Malignant tumor is one of the major public health problems seriously threatening the health of people all over the world. Great effort is being devoted to the development of theranostic nanoplatforms to satisfy the demand for precise diagnosis and efficient therapy. Recently, the Fe3O4 nanoparticles (NPs) approved by the Food and Drug Administration (FDA) have been extensively explored in cancer diagnosis and the administration of therapeutic drugs thanks to their unique properties such as T1/T2-weighted magnetic resonance (MR) imaging, magnetic targeting, magnetic hyperthermia, and photodynamic/photothermal therapy. Thus, Fe3O4 NPs together with other organic or inorganic materials are developed as theranostic nanoplatforms, thereby having the chance to compete with Gd-based contrast agents in clinics. Therefore, Fe3O4-based theranostic nanoplatforms have the potential to be used in individual therapies in the near future. In this review, the recent progress in fabricating Fe3O4-based theranostic nanoplatforms is summarized and their applications in biomedical area are also highlighted.</description><subject>Biomedical materials</subject><subject>Cancer</subject><subject>Contrast agents</subject><subject>Diagnosis</subject><subject>Gadolinium</subject><subject>Hyperthermia</subject><subject>Inorganic materials</subject><subject>Iron oxides</subject><subject>Magnetic properties</subject><subject>Magnetic resonance imaging</subject><subject>Nanomaterials</subject><subject>Nanoparticles</subject><subject>Public health</subject><subject>Regulatory agencies</subject><subject>Therapy</subject><issn>1144-0546</issn><issn>1369-9261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotjcFKAzEURYMoWKsbvyDgejQveYnNUkprhUI3ui7J5KVO1WRMpgv_3oCu7uFyuJexWxD3IJR9CJCOQiDYjzM2A2VsZ6WB88aA2AmN5pJd1docgEcDM7ZZpcOQiAoFvia1w8672ji5lL_cRGVwn5XHXHgY3CHlOlTuUuDTOxU3_vAcee9ST-WaXcSm0s1_ztnbevW63HTb3fPL8mnbjbBQUxeUIGO0E0aa2PsQvLWgopTKWyS0oMFp6hUSKW1VBA8SRbRBm-hboebs7m93LPn7RHXaH_OppHa5l1qiWaBpY7-ttkzf</recordid><startdate>20210514</startdate><enddate>20210514</enddate><creator>Zhang, Yiwei</creator><creator>Li, Xinxin</creator><creator>Zhang, Yajie</creator><creator>Wei, Jun</creator><creator>Wang, Wei</creator><creator>Dong, Changzhi</creator><creator>Xue, Yanan</creator><creator>Liu, Min</creator><creator>Pei, Renjun</creator><general>Royal Society of Chemistry</general><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>H9R</scope><scope>JG9</scope><scope>KA0</scope></search><sort><creationdate>20210514</creationdate><title>Engineered Fe3O4-based nanomaterials for diagnosis and therapy of cancer</title><author>Zhang, Yiwei ; Li, Xinxin ; Zhang, Yajie ; Wei, Jun ; Wang, Wei ; Dong, Changzhi ; Xue, Yanan ; Liu, Min ; Pei, Renjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p183t-d30e665a0626fcbddb9913f223b94e49151a5ec34ee3593f1b1240f9d56fb5933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomedical materials</topic><topic>Cancer</topic><topic>Contrast agents</topic><topic>Diagnosis</topic><topic>Gadolinium</topic><topic>Hyperthermia</topic><topic>Inorganic materials</topic><topic>Iron oxides</topic><topic>Magnetic properties</topic><topic>Magnetic resonance imaging</topic><topic>Nanomaterials</topic><topic>Nanoparticles</topic><topic>Public health</topic><topic>Regulatory agencies</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Yiwei</creatorcontrib><creatorcontrib>Li, Xinxin</creatorcontrib><creatorcontrib>Zhang, Yajie</creatorcontrib><creatorcontrib>Wei, Jun</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Dong, Changzhi</creatorcontrib><creatorcontrib>Xue, Yanan</creatorcontrib><creatorcontrib>Liu, Min</creatorcontrib><creatorcontrib>Pei, Renjun</creatorcontrib><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Illustrata: Natural Sciences</collection><collection>Materials Research Database</collection><collection>ProQuest Illustrata: Technology Collection</collection><jtitle>New journal of chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Yiwei</au><au>Li, Xinxin</au><au>Zhang, Yajie</au><au>Wei, Jun</au><au>Wang, Wei</au><au>Dong, Changzhi</au><au>Xue, Yanan</au><au>Liu, Min</au><au>Pei, Renjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineered Fe3O4-based nanomaterials for diagnosis and therapy of cancer</atitle><jtitle>New journal of chemistry</jtitle><date>2021-05-14</date><risdate>2021</risdate><volume>45</volume><issue>18</issue><spage>7918</spage><epage>7941</epage><pages>7918-7941</pages><issn>1144-0546</issn><eissn>1369-9261</eissn><abstract>Malignant tumor is one of the major public health problems seriously threatening the health of people all over the world. Great effort is being devoted to the development of theranostic nanoplatforms to satisfy the demand for precise diagnosis and efficient therapy. Recently, the Fe3O4 nanoparticles (NPs) approved by the Food and Drug Administration (FDA) have been extensively explored in cancer diagnosis and the administration of therapeutic drugs thanks to their unique properties such as T1/T2-weighted magnetic resonance (MR) imaging, magnetic targeting, magnetic hyperthermia, and photodynamic/photothermal therapy. Thus, Fe3O4 NPs together with other organic or inorganic materials are developed as theranostic nanoplatforms, thereby having the chance to compete with Gd-based contrast agents in clinics. Therefore, Fe3O4-based theranostic nanoplatforms have the potential to be used in individual therapies in the near future. In this review, the recent progress in fabricating Fe3O4-based theranostic nanoplatforms is summarized and their applications in biomedical area are also highlighted.</abstract><cop>Cambridge</cop><pub>Royal Society of Chemistry</pub><doi>10.1039/d1nj00419k</doi><tpages>24</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1144-0546 |
| ispartof | New journal of chemistry, 2021-05, Vol.45 (18), p.7918-7941 |
| issn | 1144-0546 1369-9261 |
| language | eng |
| recordid | cdi_proquest_journals_2524684622 |
| source | Royal Society Of Chemistry Journals; Alma/SFX Local Collection |
| subjects | Biomedical materials Cancer Contrast agents Diagnosis Gadolinium Hyperthermia Inorganic materials Iron oxides Magnetic properties Magnetic resonance imaging Nanomaterials Nanoparticles Public health Regulatory agencies Therapy |
| title | Engineered Fe3O4-based nanomaterials for diagnosis and therapy of cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A08%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineered%20Fe3O4-based%20nanomaterials%20for%20diagnosis%20and%20therapy%20of%20cancer&rft.jtitle=New%20journal%20of%20chemistry&rft.au=Zhang,%20Yiwei&rft.date=2021-05-14&rft.volume=45&rft.issue=18&rft.spage=7918&rft.epage=7941&rft.pages=7918-7941&rft.issn=1144-0546&rft.eissn=1369-9261&rft_id=info:doi/10.1039/d1nj00419k&rft_dat=%3Cproquest%3E2524684622%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2524684622&rft_id=info:pmid/&rfr_iscdi=true |